Refinement of systemic guinea pig deafening in hearing research: Sensorineural hearing loss induced by co-administration of kanamycin and furosemide via the leg veins
Laboratory Animals · 2023
DOI: 10.1177/00236772231167679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Animals, 2023. Verfasst von Wiebke Behrends und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Furosemide, Hearing Loss, Sensorineural. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Auditory disabilities have a large impact on the human population worldwide. Research into understanding and treating hearing disabilities has increased significantly in recent years. One of the most relevant animal species in this context is the guinea pig, which has to be deafened to study several of the hearing pathologies and develop novel therapies. Applying kanamycin subcutaneously and furosemide intravenously is a long-established method in hearing research, leading to permanent hearing loss without surgical intervention at the ear. The intravenous application of furosemide requires invasive surgery in the cervical area of the animals to expose the jugular vein, since a relatively large volume (1 ml per 500 g body weight) must be injected over a period of about 2.5 min. We have established a gentler alternative by applying the furosemide by puncture of the leg veins. For this, custom-made cannula-needle devices were built to allow the vein puncture and subsequent slow injection of the furosemide. This approach was tested in 11 guinea pigs through the foreleg via the cephalic antebrachial vein and through the hind leg via the saphenous vein. Frequency-specific hearing thresholds were measured before and after the procedure to verify normal hearing and successful deafening, respectively. The novel approach of systemic deafening was successfully implemented in 10 out of 11 animals. The Vena saphena was best suited to the application. Since the animals’ condition, post leg vein application, was better in comparison to animals deafened by exposure of the Vena jugularis, the postulated refinement that reduced animal stress was deemed successful.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Hannover Medical School, Hannover, Germany.
- Auditory Neuroethology and Neurobiology, Institute of Zoology, University of Veterinary Medicine Hannover Foundation, Germany.
- Department of Nuclear Medicine, Hannover Medical School, Germany.
- Hearing4all Cluster of Excellence, Hannover Medical School, Germany.
ORCID-Profile: Wiebke Behrends, Karl-Heinz Esser, Verena Scheper
Förderung
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Behrends, W., Ahrens, D., Bankstahl, J. P., Esser, K. H., Paasche, G., Lenarz, T., & Scheper, V. (2023). Refinement of systemic guinea pig deafening in hearing research: Sensorineural hearing loss induced by co-administration of kanamycin and furosemide via the leg veins. Laboratory Animals. https://doi.org/10.1177/00236772231167679
Vancouver
Behrends W, Ahrens D, Bankstahl JP, Esser KH, Paasche G, Lenarz T, et al. Refinement of systemic guinea pig deafening in hearing research: Sensorineural hearing loss induced by co-administration of kanamycin and furosemide via the leg veins. Laboratory Animals. 2023. doi:10.1177/00236772231167679
BibTeX
@article{Behrends2023,
author = {Behrends, Wiebke and Ahrens, Daniel and Bankstahl, Jens P and Esser, Karl-Heinz and Paasche, Gerrit and Lenarz, Thomas and Scheper, Verena},
title = {Refinement of systemic guinea pig deafening in hearing research: Sensorineural hearing loss induced by co-administration of kanamycin and furosemide via the leg veins},
journal = {Laboratory Animals},
year = {2023},
doi = {10.1177/00236772231167679}
}
EUVIMED